Usage of Mondamin procare alpha during dental implant treatment

Usage of Mondamin procare alpha during dental implant treatment - Usage of Mondamin procare alpha during dental implant treatment

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038564

Enrollment

Registered

2019-11-12

Start date

2019-11-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental implant treatment

Interventions

Evaluate the intraoral bacteria after gargle with commercially available Mondamin. Evaluate the intraoral bacteria after gargle with placebo Mondamin.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dental implant-adaptable patients without general diseases.

Exclusion criteria

Exclusion criteria: Not adaptable patients for dental implant treatment.

Design outcomes

Primary

Measure	Time frame
The purpose of this study is to examine the effect that can be expected by using Mondamin Procare alpha containing CPC, TXA and GK2 as a mouthwash after surgery related to dental implant treatment.	—

Countries

Japan

Contacts

Public ContactHidemi Nakata

Tokyo Medical and Dental University Oral Implantology and Regenerative Dental Medicine

hidemi.irm@tmd.ac.jp03-5803-5773

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026